Case of neuromyelitis otica: bilateral sensorineural hearing loss and transverse myelopathy following intrathecal chemotherapy
- 15 April 2020
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 13 (4), e234076
- https://doi.org/10.1136/bcr-2019-234076
Abstract
Neurotoxicity from intrathecally administered chemotherapeutic drugs is frequent, particularly with some agents like methotrexate, which are more prone to developing adverse effects. Myelopathy ranks among the most frequently reported neurological entities; with the diagnosis being straightforward, after ruling out infectious, metabolic, autoimmune or paraneoplastic causes. Scarcity of cases precludes evidence-based recommendations for the management of these complications. The most common therapeutic approach consists of the suspension of chemotherapy, exclusion of infectious and neoplastic causes, with prompt administration of high-dose steroids. We report a 21-year-old patient with acute lymphoblastic leukaemia, who developed acute transverse myelitis and bilateral sensorineural hearing loss, after five rounds of intrathecal methotrexate and cytarabine. Although neurotoxicity from both agents has been documented, this combination has not been previously reported.Keywords
This publication has 16 references indexed in Scilit:
- Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive PatientsPublished by Hindawi Limited ,2019
- Dorsal column myelopathy after intrathecal chemotherapy for leukemiaAmerican Journal of Hematology, 2016
- Chemotherapy-Related NeurotoxicityCurrent Neurology and Neuroscience Reports, 2016
- Myelopathy following intrathecal chemotherapy in adults: a single institution experienceJournal of Neuro-Oncology, 2015
- Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cordJournal of Clinical Neuroscience, 2013
- Myelopathy Due to Intrathecal ChemotherapyJournal of Pediatric Hematology/Oncology, 2005
- Bilateral Sensorineural Hearing Loss after Adjuvant Treatment with Cyclophosphamide, Methotrexate, Fluorouracil and Alternative Oral Medications in a Male with Breast CancerClinical Drug Investigation, 2005
- Acute ascending myelitis and encephalopathy after intrathecal cytosine arabinoside and methotrexate in an adolescent boy with acute lymphoblastic leukemiaBrain & Development, 1994
- Cytarabine and neurologic toxicity.Journal of Clinical Oncology, 1991
- Acute Cerebellar Syndrome, Conjunctivitis, and Hearing Loss Associated with Low-Dose Cytarabine AdministrationDrug Intelligence & Clinical Pharmacy, 1987